Market Cap
₹ 377 Cr
P/E
28.54
Investor Presentation
Q2 FY26
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
0
Neutral
8
Bullish
6
Bearish
15
Neutral
8
Bullish
23
Bearish
15
Neutral
0
Bullish
17
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
377 Cr
Low Risk
28.5
30.8
0.5
4.0
470.00
161.50
Sales CAGR
1Y
54.05%
3Y
9.08%
5Y
10.22%
10Y
—
Profit CAGR
1Y
123.35%
3Y
55.59%
5Y
25.09%
10Y
—
ROE
TTM
12.57%
3Y
13.96%
5Y
11.77%
10Y
—
ROCE
TTM
13.83%
3Y
18.99%
5Y
16.15%
10Y
—
Performance
MARKET LEADER
Valuation
OVERVALUED
Growth
EXCEPTIONAL
Profitability
MODERATE MARGIN
Technicals
Bullish
Risk
MODERATE RISK